Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study - Trial NCT06323590
Access comprehensive clinical trial information for NCT06323590 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Alabama at Birmingham and is currently Recruiting. The study focuses on Acute Myeloid Leukemia. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
University of Alabama at Birmingham
Timeline & Enrollment
N/A
May 02, 2024
May 01, 2028
Primary Outcome
rates of complete remission
Summary
The purpose of the study is to observe the outcomes of patients with acute myeloid leukemia
 who do not receive an immediate second round of chemotherapy after undergoing a standard
 mid-induction bone marrow biopsy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06323590
Non-Device Trial